Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 06, 2024

SELL
$306.88 - $380.0 $297,059 - $367,840
-968 Reduced 3.35%
27,968 $10.6 Million
Q3 2023

Nov 13, 2023

SELL
$315.92 - $397.36 $318,131 - $400,141
-1,007 Reduced 3.36%
28,936 $9.2 Million
Q2 2023

Aug 01, 2023

BUY
$346.15 - $392.09 $953,989 - $1.08 Million
2,756 Added 10.14%
29,943 $11.5 Million
Q1 2023

May 12, 2023

BUY
$323.56 - $373.36 $98,038 - $113,128
303 Added 1.13%
27,187 $10.2 Million
Q4 2022

Feb 07, 2023

SELL
$248.67 - $334.17 $718,158 - $965,082
-2,888 Reduced 9.7%
26,884 $8.88 Million
Q3 2022

Nov 02, 2022

SELL
$263.81 - $337.27 $168,574 - $215,515
-639 Reduced 2.1%
29,772 $7.86 Million
Q2 2022

Aug 02, 2022

SELL
$301.4 - $428.42 $251,066 - $356,873
-833 Reduced 2.67%
30,411 $9.52 Million
Q1 2022

May 02, 2022

SELL
$379.46 - $424.54 $464,459 - $519,636
-1,224 Reduced 3.77%
31,244 $13 Million
Q4 2021

Feb 02, 2022

SELL
$373.53 - $434.12 $386,603 - $449,314
-1,035 Reduced 3.09%
32,468 $13.6 Million
Q3 2021

Nov 08, 2021

SELL
$396.76 - $455.92 $709,803 - $815,640
-1,789 Reduced 5.07%
33,503 $13.8 Million
Q2 2021

Aug 11, 2021

SELL
$372.36 - $412.07 $720,888 - $797,767
-1,936 Reduced 5.2%
35,292 $14 Million
Q1 2021

May 03, 2021

SELL
$357.26 - $392.57 $723,094 - $794,561
-2,024 Reduced 5.16%
37,228 $14.3 Million
Q4 2020

Feb 02, 2021

SELL
$319.05 - $363.32 $1.51 Million - $1.71 Million
-4,718 Reduced 10.73%
39,252 $14.3 Million
Q3 2020

Nov 12, 2020

SELL
$280.08 - $347.78 $6.69 Million - $8.31 Million
-23,891 Reduced 35.21%
43,970 $14.8 Million
Q2 2020

Aug 13, 2020

SELL
$270.93 - $320.3 $322,135 - $380,836
-1,189 Reduced 1.72%
67,861 $19.2 Million
Q1 2020

May 15, 2020

BUY
$243.44 - $359.98 $16.8 Million - $24.9 Million
69,050 New
69,050 $19 Million

Others Institutions Holding COO

About COOPER COMPANIES, INC.


  • Ticker COO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 49,346,000
  • Market Cap $4.92B
  • Description
  • The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses corr...
More about COO
Track This Portfolio

Track Geneva Capital Management LLC Portfolio

Follow Geneva Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geneva Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geneva Capital Management LLC with notifications on news.